Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Clinical trial NCT01169337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01169337
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-24
- Primary completion
- 2019-01-25
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.